Cancer-Carcinoma-Pancreatic Ductal
| Title: | A Phase III Study of BBI-608 Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma |
| Description: | This is a randomized, open-label, multi-center, phase 3 study of napabucasin plus weekly nab-paclitaxel with gemcitabine versus weekly nab-paclitaxel with gemcitabine for adult patients with Metastatic Pancreatic Ductal Adenocarcinoma. |
| Drug/Procedure: | Napabucasin; Nab-paclitaxel; Gemcitabine |
| NCT Number: | 02993731 |
| Notes: | Phase 3 |
| Start Date: | 10/23/17 |
| Status: | Recruiting |
| Principal Name: | Bobby Chawla, MD |
| Contact Name: | Tina Schied, CCRC |
| Phone: | (208)367-3481 |